Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer

Menopause International

Volumn 14, Issue 1, 2008, Pages 6-12

  Powles, Trevor J ^a   Howell, Anthony ^b   Evans, D Gareth ^c   McCloskey, Eugene V ^d   Ashley, Sue ^e   Greenhalgh, Rosemary ^b   Affen, Jenny ^b   Flook, Lesley Ann ^e   Tidy, Alwynne ^e  

^a Parkside Oncology Clinic   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Isoflavones; Menopause; Phytoestrogens; Red clover

Indexed keywords

CHOLESTEROL; FOLLITROPIN; ISOFLAVONE DERIVATIVE; PLACEBO; PHYTOESTROGEN;

ADULT; AGED; ARTHRALGIA; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BONE DENSITOMETRY; BONE DENSITY; BREAST; BREAST CANCER; CANCER PREVENTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; ENDOMETRIUM; EYE DISEASE; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FLUID RETENTION; FOLLITROPIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HAIR DISEASE; HEADACHE; HOT FLUSH; HUMAN; HUMAN TISSUE; INDIGESTION; LETHARGY; MAMMOGRAPHY; MENSTRUAL CYCLE; MOOD CHANGE; NAIL DISEASE; NAUSEA; PATIENT MONITORING; PERIODIC MEDICAL EXAMINATION; PILOT STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RED CLOVER; SIDE EFFECT; SKIN TOXICITY; SLEEP DISORDER; TRANSVAGINAL ECHOGRAPHY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VAGINA DISCHARGE; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; BREAST TUMOR; CLOVER; DRUG EFFECT; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PHYTOTHERAPY; PREMENOPAUSE;

AGED; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOFLAVONES; MIDDLE AGED; PHYTOESTROGENS; PHYTOTHERAPY; POSTMENOPAUSE; PREMENOPAUSE; TRIFOLIUM;

EID: 46749133785     PISSN: 13621807     EISSN: 17404568     Source Type: Journal    
DOI: 10.1258/mi.2007.007033     Document Type: Article

References (30)

1. Barentsen R. Red clover isoflavones and menopausal health. J Br Menopause Soc 2004;10(Suppl.S1):4-7 (Pubitemid 38515395)
2. Imhof M, Gocan A, Reithmayr F, et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 2006;55:76-81 (Pubitemid 44109945)
3. Setchell K, Adlercreutz H. Mammalian lignans and phytoestrogens: recent studies on their formation, metabolism and biological role in health and disease. In: Rowland I ed. Role of the Gut Flora in Toxicity and Cancer. London: Academic Press, 1988:315-345
4. Fotsis T, Pepper M, Adlercreutz H, et al. Genistein, a dietary derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 1993;90:2690-2694 (Pubitemid 23113482)
5. Messina M, Persky V, Setchell K, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;21:113-131 (Pubitemid 24127628)
6. Yamamoto S, Sobue T, Kobayashi M, et al. Soy, isoflavones and breast cancer risk in Japan. J Nat Cancer Inst 2003;95:906-913 (Pubitemid 36833882)
7. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/ progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49-57 (Pubitemid 34705518)
8. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333 (Pubitemid 34761611)
9. Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543-1551 (Pubitemid 40615403)
10. Clanget C, Hinke V, Lange S, et al. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI. Exp Clin Endocrinol Diabetes 2005;113:529-533
11. Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 2006;55:203-211 (Pubitemid 44397351)
12. Thompson Coon J, Pittler MH, Ernst E. The role of red clover (Trifolium pratense) isoflavones in women's reproductive health: a systematic review and meta-analysis of randomised clinical trials. Focus Altern Complement Ther 2003;8:544
13. van de Weijer PHM, Barentsen R. Isoflavones from red clover (Promensil®) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187-193 (Pubitemid 34876810)
14. Nelson H, Vesco K, Haney E, et al. Non-hormonal therapies for menopausal hot flashes. JAMA 2006;295:2057-2071
15. Boekhout AH, Beijnen JH, Schellens JHM. Symptoms and treatment in cancer therapy-induced early menopause. Oncologist 2006;6:641-654 (Pubitemid 43967619)
16. Kurzer MS. Hormonal effects of soy isoflavones: studies in premenopausal and postmenopausal women. J Nutr 2000;130:p660S-1S (Pubitemid 30118090)
17. Atkinson C, Compston JE, Day NE, et al. The effects of phytoestrogen isoflavones on bone density in women: a double blind randomised placebo controlled trial. Am J Clin Nutr 2004;79:326-333 (Pubitemid 41095988)
18. Zhuo X-G, Melby MK, Watanabe S. Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J Nutr 2004;134:2395-2400 (Pubitemid 39201614)
19. Kimira M, Arai Y, Shimoi K, Watanabe S. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol 1998;8:168-175 (Pubitemid 128788426)
20. Powles T, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998;352:98-101 (Pubitemid 28321321)
21. Atkinson C, Warren RM, Sala E, et al. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res 2004;6:R170-9
22. Gao J,Warren R,Warren-Forward H, et al. Reproducibility of visual assessment on mammographic density. Breast Cancer Res Treat 2007; [Epub ahead of print]
23. Jeri AR. The use of an isoflavone supplement to relieve hot flushes. Female Patient 2002;27:35-37
24. Maskarinec G, Williams AE, Carlin L. Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 2003;12:165-169 (Pubitemid 36543431)
25. Maskarinec G, Takata Y, Franke AA, et al. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 2004;134:3089-3094 (Pubitemid 39470089)
26. Powles T. Isoflavones and women's health. Breast Cancer Res 2004;6:140-142
27. Hale GE, Hughes CL, Robboy SJ, et al. A double blind randomised study on the effects of red clover isoflavones on the endometrium. Menopause 2001;8:338-346 (Pubitemid 32826166)
28. Baber R, Templeman C, Moreton T, et al. Randomised placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92 (Pubitemid 29333647)
29. Woods R, Colville N, Blazquez J, et al. Effects of red clover isoflavones (Promensil) versus placebo on uterine endometrium, vaginal maturation index and the uterine artery in healthy post-menopausal women. J Br Menopause Soc 2003;(S2):23
30. Howes JB, Howes LG. Content of isoflavone-containing preparations. Med J Aust 2002;176:135-136